Anyone know, can anavex apply for a new patent for the method in which they create 2-73 - for each indication? - same as this one but for each indication?
it must be noted that most of the text delineates how the drug will be used to treat Alzheimer’s disease.
Thanks Falconer. This info you mentioned above is no doubt gleaned from the very powerful Ph 2a that has cast so much doubt over the years as a big "market" waste of time!